Noemi Di Lorenzo

Dr. Noemi Di Lorenzo

University of Palermo, Palermo, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2022 in Anatomia
Verified
Journal Article
Open access
PDF file
Rosario BaroneRosario Barone
Rosario Barone
Agata Grazia D'AmicoAgata Grazia D'Amico
Agata Grazia D'Amico
NLNoemi Di Lorenzo
Noemi Di Lorenzo
GGGrazia Laura Di Grado
Grazia Laura Di Grado
EMEgle Matranga
Egle Matranga
SWSławomir Wójcik
Sławomir Wójcik
The musculocutaneous nerve (MCN) is the terminal branch of the lateral cord of the brachial plexus, and emerges at the inferior border of pectoralis minor muscle. The nerve can interact with the median nerve (MN), adhering to the nerve and sharing fibers with it. During anatomical dissection of twelve cadavers, we have detected a rare variation of the anastomosis between MCN and MN. The knowledge of this anatomical variation could be of great relevance during surgical and clinical practices.


15 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RVRoberta Vella
Roberta Vella
Duilio PaganoDuilio Pagano
Duilio Pagano
FBFabrizio Di Benedetto
Fabrizio Di Benedetto
SPSergio Li Petri
Sergio Li Petri
PBPasquale Bonsignore
Pasquale Bonsignore
Salvatore GruttadauriaSalvatore Gruttadauria
Salvatore Gruttadauria
Background/Objectives: The increasing adoption of laparoscopic liver resection (LLR) and changes in clinical management may influence access to curative treatments for patients on the liver transplant waiting list. We aimed to analyze temporal trends in LLR use and to explore the association between the proportion of LLR and the dropout rate from the intention-to-treat (ITT) population. A secondary objective was to assess the risk of dropout or death versus curative treatment (transplantation or resection) in patients with hepatocellular carcinoma (HCC) compared with non-HCC candidates using a competing-risk model. Methods: We performed a retrospective cohort study of all patients listed for liver transplantation between 2015 and 2023. Annual rates of LLR and dropout were calculated, and their correlation was evaluated using Spearman’s rho. The risk of dropout/death and competing curative events (OLT, resection, or thermal ablation) was assessed using Fine–Gray competing-risk regression, adjusted for HCC status. Results: From 2015 to 2023, LLR accounted for a progressively increasing proportion of liver resections. A significant negative correlation was observed between annual LLR rates and dropout rates (ρ = −0.78, p = 0.008), indicating fewer ITT failures with greater LLR adoption. In the competing-risk analysis, HCC patients had a significantly lower subdistribution hazard for dropout/death (SHR 0.27, 95% CI 0.18–0.42, p < 0.001) and a higher probability of receiving a curative treatment (SHR 1.65, 95% CI 1.40–1.94, p < 0.001). Conclusions: The increased use of LLR was associated with improved access to curative therapies and a reduced dropout risk on the liver transplant waiting list. HCC patients showed a more favorable competing-risk profile compared with non-HCC candidates.